Rituximab and Combination Chemotherapy With or Without Lenalidomi

PRIMARY OBJECTIVES: I. Progression-free survival (PFS). SECONDARY OBJECTIVES: I. Response rate (RR). II. Complete remission (CR) rate as defined by positron emission tomography (PET)-computed tomography (CT) criteria. III. Overall survival (OS).

May 13, 2016